Molecular mechanism and therapy application of necrosis during myocardial injury.
Necrosis is an ancient topic which gains new attraction in the research area these years. There is no doubt that some necrosis can be regulated by genetic manipulation other than an accidental cell death resulting from physical or chemical stimuli. Recent advances in the molecular mechanism underlying the programmed necrosis show a fine regulation network which indicates new therapy targets in human diseases. Heart diseases seriously endanger our health and have high fatality rates in the patients. Cell death of cardiac myocytes is believed to be critical in the pathogenesis of heart diseases. Although necrosis is likely to play a more important role in cardiac cell death than apoptosis, apoptosis has been paid much attention in the past 30 years because it used to be considered as the only form of programmed cell death. However, recent findings of programmed necrosis and the related signalling pathways have broadened our horizon in the field of programmed cell death and promote new pharmacological application in the treatment of heart diseases. In this review, we summarize the advanced progress in these signalling pathways and discuss the pathos-physiological relevance and therapeutic implication of targeting necrosis in heart diseases treatment.
['Xu|Tao|T|0000-0003-1698-5556', 'Ding|Wei|W|', 'Tariq|Muhammad Akram|MA|', 'Wang|Yu|Y|', 'Wan|Qinggong|Q|', 'Li|Mengyang|M|0000-0003-1491-4105', 'Wang|Jianxun|J|']
D000818:Animals D006331:Heart Diseases D006801:Humans D008928:Mitochondria D009206:Myocardium D009336:Necrosis D053218:Receptors, Death Domain D015398:Signal Transduction
therapy application programmed necrosis heart diseases death receptor pathway mitochondrial pathway